BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9560832)

  • 21. Current and potential uses of low molecular weight heparin: a review and an economic analysis.
    Seo P; Locke CF
    Am J Manag Care; 2000 Apr; 6(4):498-506; quiz 507-8. PubMed ID: 10977456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From prevention to therapy of thromboembolic processes: low-molecular heparin in body-weight adapted dosages].
    Internist (Berl); 1998 May; 39(5 Suppl Niedermole):1-16. PubMed ID: 9648001
    [No Abstract]   [Full Text] [Related]  

  • 23. Low molecular weight heparins in cardiovascular medicine.
    De Lorenzo F; Dotsenko O; Kakkar VV
    Minerva Cardioangiol; 2005 Dec; 53(6):585-603. PubMed ID: 16333240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.
    Hull RD; Pineo GF
    Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024
    [No Abstract]   [Full Text] [Related]  

  • 25. New anticoagulants & clinical trials.
    Haideri N; Patel H
    Mo Med; 2009; 106(1):60-4. PubMed ID: 19245126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight heparins. A pharmacologic overview.
    Hillis LB
    Adv Nurse Pract; 1997 Oct; 5(10):53-6. PubMed ID: 9459986
    [No Abstract]   [Full Text] [Related]  

  • 27. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 28. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight heparin for thromboprophylaxis.
    Camporese G; Bernardi E
    Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
    Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
    Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparins.
    Weitz JI
    N Engl J Med; 1997 Sep; 337(10):688-98. PubMed ID: 9278467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Heparin therapy in pregnant women].
    Schleich JM; Laurent M; Almange C
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1291-300. PubMed ID: 11794972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
    Hirsh J
    Curr Opin Hematol; 1998 Sep; 5(5):360-5. PubMed ID: 9776217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.